Skip to main content
. 2022 Aug 9;31(6):927–938. doi: 10.1177/10668969221117243

Figure 4.

Figure 4.

Pan-keratin immunostaining and recurrence-free survival (A) and overall survival (B) in clear cell renal cancer. Pan-keratin immunostaining in NST breast cancer and overall survival (C).